Table 12.
Infants (12 weeks–11 months) | Toddlers (12–35 months) | Children (3–9 years) | Adolescents (10–17 years) | Adults (18–64 years) | The elderly (≥ 65 years) | |
---|---|---|---|---|---|---|
Maximum level exposure assessment scenario | ||||||
|
0.06–3.6 0.2–15.8 | 0.9–12.8 2.9–31.4 | 1.9–11.5 5.9–31.3 | 1.3–6.2 4.0–18.6 | 0.7–6.7 2.4–15.9 | 0.4–4.9 1.9–12.7 |
Refined exposure assessment scenarios | ||||||
Brand‐loyal scenario | ||||||
|
0.05–3.5 0.1–14.3 | 0.8–10.0 2.6–28.0 | 1.7–9.7 5.2–25.4 | 1.1–5.0 3.3–14.9 | 0.6–5.5 2.0–13.1 | 0.4–4.2 1.7–10.4 |
Non‐brand‐loyal scenario | ||||||
|
0.03–2.9 0.1–9.9 | 0.6–6.0 1.9–27.5 | 0.9–6.9 2.5–23.7 | 0.6–3.6 1.6–13.2 | 0.3–3.8 1.2–9.5 | 0.2–2.8 0.9–7.1 |
bw: body weight.